ATRS

NASDAQ:ATRS

Antares Pharma, Inc.

  • Stock

USD

Last Close

5.58

24/04 19:47

Volume Today

1.76M

Avg: 5.23M

PE Ratio

20.05

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
-35.15M
-
-20.66M
41.23%
-24.34M
17.81%
-16.74M
31.21%
-6.51M
61.09%
-2.03M
68.89%
56.20M
2,872.62%
46.29M
17.64%
depreciation and amortization
1.22M
-
1.57M
28.23%
1.86M
18.53%
2.10M
13.08%
2.72M
29.47%
2.56M
6.13%
2.63M
2.74%
3.90M
48.50%
deferred income tax
-46.98M
-
13.94M
129.67%
stock based compensation
2.62M
-
3.66M
39.40%
2.52M
31.13%
3.49M
38.51%
4.93M
41.17%
6.47M
31.32%
7.95M
22.84%
8.02M
0.84%
change in working capital
1.36M
-
-13.68M
1,106.13%
3.74M
127.35%
-11.63M
410.82%
-6.81M
41.43%
-18.36M
169.52%
469K
102.55%
15.53M
3,212.15%
accounts receivables
-2.48M
-
-4.42M
78.44%
-1.14M
74.28%
-2.80M
145.97%
-7.10M
153.72%
-16.09M
126.72%
-7.13M
55.71%
-14.48M
103.09%
inventory
-2.95M
-
-564.47K
80.86%
-350.94K
37.83%
-4.30M
1,126.41%
-2.67M
38.03%
-4.97M
86.54%
-2.73M
45.17%
152K
105.57%
accounts payables
2.69M
-
-3.49M
230.00%
2.86M
181.81%
-1.52M
153.24%
5.16M
439.29%
926K
82.07%
2.59M
180.13%
2.19M
15.61%
other working capital
4.10M
-
-5.20M
226.77%
2.37M
145.62%
-3.00M
226.72%
-2.21M
26.46%
1.79M
180.90%
7.73M
332.62%
27.67M
257.90%
other non cash items
3.61M
-
908.91K
74.82%
1.02M
12.49%
-317K
131.00%
-11.65M
3,574.13%
742K
106.37%
1.06M
42.45%
-51.06M
4,930.56%
net cash provided by operating activities
-26.33M
-
-28.20M
7.08%
-15.19M
46.12%
-23.09M
51.98%
-17.32M
24.99%
-10.62M
38.72%
21.32M
300.85%
36.62M
71.76%
investments in property plant and equipment
-5.65M
-
-6.69M
18.28%
-5.01M
25.12%
-1.27M
74.67%
-894K
29.50%
-2.35M
162.86%
-14.62M
521.91%
-6.62M
54.72%
acquisitions net
1.04M
-
101K
-
purchases of investments
-15.04M
-
-9.96M
-
-22.64M
-
-1.25M
-
sales maturities of investments
24M
-
6M
75%
15M
150%
5M
66.67%
5M
0%
22.50M
-
other investing activites
-1.04M
-
1.80M
-
7.50M
316.67%
5M
33.33%
282K
94.36%
4.01M
1,321.99%
net cash used for investing activites
18.35M
-
-15.72M
185.71%
9.99M
163.55%
-4.33M
143.34%
11.61M
367.98%
-20.00M
272.28%
8.17M
140.85%
-3.85M
147.17%
debt repayment
-1.37M
-
-40M
2,826.12%
common stock issued
42.85M
-
7.11M
-
7.78M
9.38%
common stock repurchased
dividends paid
other financing activites
2.95M
-
-56.97K
101.93%
17.46K
130.65%
26.27M
150,366.75%
-69K
100.26%
18.14M
26,386.96%
1.81M
90.00%
20.01M
1,003.09%
net cash used provided by financing activities
2.95M
-
42.79M
1,350.29%
17.46K
99.96%
26.27M
150,366.75%
7.04M
73.19%
25.92M
267.91%
447K
98.28%
-19.99M
4,572.04%
effect of forex changes on cash
-2.65K
-
-733
72.32%
58
107.91%
-1K
1,824.14%
1K
200%
2K
-
-1K
150%
net change in cash
-5.04M
-
-1.13M
77.57%
-5.18M
358.68%
-1.15M
77.76%
1.33M
215.35%
-4.69M
452.71%
29.94M
738.16%
12.78M
57.32%
cash at beginning of period
39.07M
-
34.03M
12.90%
32.90M
3.32%
27.71M
15.76%
26.56M
4.16%
27.89M
5.01%
23.20M
16.82%
53.14M
129.03%
cash at end of period
34.03M
-
32.90M
3.32%
27.71M
15.76%
26.56M
4.16%
27.89M
5.01%
23.20M
16.82%
53.14M
129.03%
65.91M
24.04%
operating cash flow
-26.33M
-
-28.20M
7.08%
-15.19M
46.12%
-23.09M
51.98%
-17.32M
24.99%
-10.62M
38.72%
21.32M
300.85%
36.62M
71.76%
capital expenditure
-5.65M
-
-6.69M
18.28%
-5.01M
25.12%
-1.27M
74.67%
-894K
29.50%
-2.35M
162.86%
-14.62M
521.91%
-6.62M
54.72%
free cash flow
-31.99M
-
-34.89M
9.06%
-20.20M
42.09%
-24.36M
20.59%
-18.22M
25.23%
-12.96M
28.83%
6.71M
151.72%
30.00M
347.46%

All numbers in USD (except ratios and percentages)